Hormone therapy should be first choice for menopause symptoms, says ACOG
The American College of Obstetricians and Gynecologists released new guidance recommending hormone therapy for hot flashes, night sweats, and sleep problems.

Hormone therapy should be a first choice for easing hot flashes, night sweats, and the sleep problems they cause, according to the American College of Obstetricians and Gynecologists (ACOG). The group released the new guidance on Thursday, providing its most detailed menopause advice to date regarding treatments for mood changes, sleep, and hot flashes.
ACOG gave hormone therapy a strong rating, indicating the benefits outweigh the risks for most women with these symptoms. This does not apply to women with medical reasons to avoid hormones, such as certain cancers, a stroke, or past blood clots. Between 50% and 92% of women in menopause experience night sweats or hot flashes. Sleep trouble and depression are also common during this stage.
For women choosing hormones, ACOG advises starting before age 60 or within 10 years after menopause begins. The decision should weigh personal risk of breast cancer, heart disease, and blood clots, alongside age, health history, and symptoms. This guidance shifts from 2014 advice, which urged doctors to prescribe the shortest time at the lowest dose. The new guidance calls for regular check-ins instead of strict limits.
Dr. Bruce Pier, a co-author of the guidance, said misconceptions about the risks of hormone therapy have affected the willingness of some patients to use it and some clinicians to prescribe it.
Other options include some antidepressants to ease depression and hot flashes, or nondrug options like mindfulness, exercise, hypnosis, acupuncture, and cognitive behavioral therapy. ACOG says these generally work best alongside medication, though evidence for some is limited.
The guidance also notes that income, culture, and race can shape the care women receive and how they experience menopause. ACOG plans to release separate guidance in 2027 regarding urinary tract infections and vaginal dryness, which are part of genitourinary syndrome of menopause.
Key facts
- ACOG recommends hormone therapy as a first choice for hot flashes and night sweats.
- Between 50% and 92% of women in menopause experience hot flashes or night sweats.
- ACOG advises starting hormone therapy before age 60 or within 10 years after menopause begins.
Three perspectives
Neutral
The new guidance recommends hormone therapy as a primary treatment for menopause symptoms while noting that decisions should be based on individual health history and risks.
Positive
ACOG provides detailed advice on various treatments, including newer nonhormonal drugs and nondrug options like exercise and mindfulness.
Negative
Misconceptions about the risks of hormone therapy have affected the willingness of some clinicians to prescribe it and some patients to use it.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.